#MicrobiomeMedicine

Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study /PRNewswire/ -- Siolta Therapeutics, a clinical-stage biotech company developing first-in-class live biotherapeutic products (LBPs), today announced positive...

From postdoc to CEO: Nikole Kimes, a former member of Sue Lynch's lab, shares an exciting advancement for allergic disease prevention through microbiome intervention. #CareerPathways #MicrobiomeMedicine #BCMM www.prnewswire.com/news-release...